Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Leo reports cyclic phosphonamide MMP inhibitors with antitumor activity

Sep. 12, 2002

NV-1020 completes phase I in colorectal cancer metastatic to the liver

Sep. 12, 2002

Genta evaluates Genasense in children with solid tumors

Sep. 10, 2002

Novel antitumor compounds isolated from Clavularia corals

Sep. 9, 2002

Novel inhibitors of VEGF expression covered by Mercian patent

Sep. 9, 2002

Arimidex approved in early breast cancer

Sep. 9, 2002

Bay-43-9006 enters phase II

Sep. 9, 2002

Eligard 22.5 mg launched

Sep. 9, 2002

TLK-286 to enter phase III by first quarter 2003

Sep. 9, 2002

Ark and Tanabe collaborate on cachexia product development

Sep. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...